| |
| |
|
| Insider
Information: |
Schuler Jack W |
| Relationship: |
|
| City: |
Lake Forest |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
13 |
|
| Direct
Shares |
27,956,178 |
|
|
Indirect Shares
|
61,134,751 |
|
|
| Direct
Value |
$199,928,913 |
|
|
|
Indirect Value
|
$174,216,753 |
|
|
| Total
Shares |
89,090,929 |
|
|
| Total
Value |
$374,145,666 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
54
|
96
|
|
Stock
price went up :
|
14
|
2
|
| Stock
price went down : |
40
|
94
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -25.7%
|
-5,816.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Stericycle Inc |
SRCL |
Director |
2018-03-01 |
626,142 |
2018-03-01 |
56,460 |
Premium* |
|
|
Ventana Medical Systems Inc |
VMSI |
Director |
2008-02-08 |
0 |
2008-02-11 |
0 |
Premium* |
|
|
QuidelOrtho Corporation |
QDEL |
Director, 10% Owner |
2020-05-14 |
3,103,249 |
2018-01-22 |
3,414,053 |
Premium* |
|
|
Oncternal Therapeutics Inc |
ONCT |
10% Owner |
2014-03-21 |
6,165,261 |
2010-12-14 |
21,500 |
Premium* |
|
|
Transition Therapeutics |
TTHI |
10% Owner |
2011-11-22 |
2,823,010 |
2011-11-22 |
0 |
Premium* |
|
|
Yield10 Bioscience Inc |
YTEN |
|
2015-06-19 |
2,185,652 |
2023-12-20 |
63,789 |
Premium* |
|
|
Accelr8 Technology Corp |
AXDX |
Director, 10% Owner |
2024-05-29 |
15,488 |
2024-05-29 |
8,515,885 |
Premium* |
|
|
Aspira Womens Health Inc |
AWH |
|
2017-08-31 |
6,673,029 |
2023-07-24 |
1,883,656 |
Premium* |
|
|
Hansen Medical Inc |
HNSN |
Director |
2014-02-26 |
5,319,769 |
2014-02-26 |
13,249,640 |
Premium* |
|
|
Biolase Inc |
BIOL |
|
|
0 |
2020-02-11 |
759,820 |
Premium* |
|
|
Neos Therapeutics, Inc. |
NEOS |
10% Owner |
2015-07-28 |
1,044,578 |
2017-02-17 |
2,338,671 |
Premium* |
|
|
Soleno Therapeutics Inc |
SLNO |
|
2018-12-21 |
0 |
2022-12-09 |
36,595 |
Premium* |
|
|
Biodesix Inc |
BDSX |
|
2020-10-30 |
0 |
2024-05-23 |
30,794,682 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
634 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 11 of 26
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2009-11-02 |
4 |
B |
$9.48 |
$40,764 |
D/D |
4,300 |
2,890,890 |
2.37 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2021-05-18 |
4 |
S |
$1.03 |
$42,456 |
I/I |
(41,195) |
9,707,848 |
0 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2021-01-20 |
4 |
S |
$2.10 |
$42,484 |
I/I |
(20,277) |
10,954,255 |
0 |
% |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2014-09-22 |
4 |
B |
$16.44 |
$42,547 |
I/I |
2,588 |
10,716,589 |
2.25 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2019-04-15 |
4 |
B |
$1.99 |
$43,675 |
I/I |
21,953 |
720,600 |
1.5 |
- |
|
| BDSX |
Biodesix Inc |
|
• • • |
2023-05-24 |
4 |
B |
$1.25 |
$43,980 |
I/I |
35,308 |
20,510,704 |
0.01 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2022-08-12 |
4 |
S |
$2.65 |
$44,238 |
I/I |
(16,667) |
598,345 |
0 |
% |
|
| BIOL |
Biolase Inc |
10% Owner |
– – • |
2015-10-23 |
4 |
B |
$0.92 |
$44,390 |
I/I |
48,250 |
4,769,272 |
1.5 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2015-04-16 |
4 |
B |
$22.33 |
$44,660 |
I/I |
2,000 |
10,763,173 |
2.25 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2010-05-07 |
4 |
B |
$3.12 |
$45,230 |
D/D |
14,515 |
3,648,294 |
2.37 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2015-08-25 |
4 |
B |
$18.20 |
$45,500 |
I/I |
2,500 |
11,231,179 |
2.25 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2010-03-11 |
4 |
B |
$3.64 |
$46,289 |
D/D |
12,700 |
3,700,261 |
2.37 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-10-18 |
4 |
S |
$3.35 |
$46,304 |
I/I |
(13,822) |
808,650 |
0 |
% |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2016-05-20 |
4 |
B |
$11.04 |
$47,141 |
I/I |
4,270 |
12,071,158 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2014-08-21 |
4 |
B |
$16.79 |
$48,691 |
I/I |
2,900 |
10,681,590 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2022-01-04 |
4 |
B |
$4.93 |
$49,300 |
I/I |
10,000 |
18,518,690 |
2.25 |
% |
|
| BIOL |
Biolase Inc |
10% Owner |
– – • |
2015-10-20 |
4 |
B |
$0.95 |
$49,498 |
I/I |
52,103 |
4,179,667 |
1.5 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2020-04-24 |
4 |
B |
$10.00 |
$50,010 |
I/I |
5,001 |
14,685,245 |
2.25 |
% |
|
| BDSX |
Biodesix Inc |
|
• • • |
2023-08-21 |
4 |
B |
$1.64 |
$53,411 |
I/I |
32,556 |
30,611,915 |
0.01 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2022-08-26 |
4 |
S |
$2.41 |
$54,675 |
I/I |
(22,681) |
466,666 |
0 |
% |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2015-01-05 |
4 |
B |
$18.27 |
$54,810 |
I/I |
3,000 |
10,734,589 |
2.25 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2010-12-14 |
4 |
S |
$2.58 |
$55,470 |
I/I |
(21,500) |
21,500 |
0 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2010-06-14 |
4 |
B |
$11.25 |
$56,264 |
I/I |
5,000 |
651,126 |
2.1 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2011-05-03 |
4 |
B |
$13.01 |
$59,746 |
D/D |
4,591 |
3,146,879 |
2.39 |
- |
|
| BIOL |
Biolase Inc |
10% Owner |
– – • |
2015-11-23 |
4 |
B |
$0.93 |
$60,324 |
I/I |
64,865 |
5,885,603 |
1.5 |
- |
|
634 Records found
|
|
Page 11 of 26 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
